Literature DB >> 22521346

Alpha-fetoprotein acts as a novel signal molecule and mediates transcription of Fn14 in human hepatocellular carcinoma.

Shanshan Wang1, Wei Jiang, Xiangmei Chen, Chao Zhang, Hui Li, Wenting Hou, Zhongmin Liu, Michael A McNutt, Fengmin Lu, Gang Li.   

Abstract

BACKGROUND & AIMS: The function of cytoplasmic AFP as a regulatory factor in the growth of tumor cells has been well defined. However, its precise mechanism of action and its clinical significance remain to be worked out.
METHODS: Specimens from HCC patients were analyzed by using immunohistochemistry, co-immunoprecipitation (CoIP), and chromatin immunoprecipitation (ChIP) assays to evaluate the role of AFP in RAR signaling-mediated carcinogenesis. Quantitative real-time reverse transcription PCR, Western blotting, confocal microscopy, CoIP, GST pull-down, siRNA, gene transfection, and ChIP assays were also used for analysis of cell lines.
RESULTS: RAR is able to interact with cytoplasmic AFP and binds to the element of the regulatory region of the Fn14 gene in the neoplastic tissue of HCC patients. An assay of hepatocyte cell lines of differing AFP expression showed that cytoplasmic AFP is able to block ATRA-induced nuclear translocation of RAR and expression of the Fn14 gene. Knockdown of AFP in siRNA-transfected HepG2 and Bel7402 cells led to greater binding of RAR to its response element. The expression of the Fn14 gene was therefore up regulated as reflected by increases in mRNA and protein levels. Conversely, transfection of HLE and L02 cells (AFP negative) with the afp gene resulted in apparent reduction of RAR binding to DNA and Fn14 protein.
CONCLUSIONS: Demonstration of the involvement of cytoplasmic AFP in RAR-mediated expression of the Fn14 gene strongly indicates AFP plays a signal molecule-like role in the regulation of hepatocellular carcinoma growth.
Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22521346     DOI: 10.1016/j.jhep.2012.03.029

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  27 in total

1.  SULF1/SULF2 reactivation during liver damage and tumour growth.

Authors:  Kurtis Graham; Joshua I Murphy; Gurtej K Dhoot
Journal:  Histochem Cell Biol       Date:  2016-03-25       Impact factor: 4.304

2.  Sustained endoplasmic reticulum stress inhibits hepatocyte proliferation via downregulation of c-Met expression.

Authors:  Yihuai He; Jun Long; Weiwei Zhong; Yu Fu; Ying Li; Shide Lin
Journal:  Mol Cell Biochem       Date:  2014-01-05       Impact factor: 3.396

3.  Role of Fn14 in acute alcoholic steatohepatitis in mice.

Authors:  Gamze Karaca; Guanhua Xie; Cynthia Moylan; Marzena Swiderska-Syn; Cynthia D Guy; Leandi Krüger; Mariana Verdelho Machado; Steve S Choi; Gregory A Michelotti; Linda C Burkly; Anna Mae Diehl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-12-18       Impact factor: 4.052

4.  Nonsecreted cytoplasmic alpha-fetoprotein: a newly discovered role in intracellular signaling and regulation. An update and commentary.

Authors:  G J Mizejewski
Journal:  Tumour Biol       Date:  2015-07-12

5.  The antitumor effect of TIG3 in liver cancer cells is involved in ERK1/2 inhibition.

Authors:  Yan Xu; Ting Chen; Degui Liao; Xiaoqin Wu; Yun Zhong; Shiming Liu; Hui Yang; Yuqiang Nie
Journal:  Tumour Biol       Date:  2016-03-08

6.  Antitumor activity of a humanized, bivalent immunotoxin targeting fn14-positive solid tumors.

Authors:  Hong Zhou; Walter N Hittelman; Hideo Yagita; Lawrence H Cheung; Stuart S Martin; Jeffrey A Winkles; Michael G Rosenblum
Journal:  Cancer Res       Date:  2013-05-30       Impact factor: 12.701

7.  A novel anti-alpha-fetoprotein single-chain variable fragment displays anti-tumor effects in HepG2 cells as a single agent or in combination with paclitaxel.

Authors:  Xiaonan Ji; Yanli Shen; Hao Sun; Xiangdong Gao
Journal:  Tumour Biol       Date:  2016-01-28

Review 8.  Emerging roles of cancer-testis antigenes, semenogelin 1 and 2, in neoplastic cells.

Authors:  Oleg Shuvalov; Alyona Kizenko; Alexey Petukhov; Olga Fedorova; Alexandra Daks; Nikolai Barlev
Journal:  Cell Death Discov       Date:  2021-05-08

9.  Alpha-fetoprotein activates AKT/mTOR signaling to promote CXCR4 expression and migration of hepatoma cells.

Authors:  Mingyue Zhu; Junli Guo; Hua Xia; Wei Li; Yan Lu; Xu Dong; Yi Chen; Xieju Xie; Shigan Fu; Mengsen Li
Journal:  Oncoscience       Date:  2015-01-06

10.  CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.

Authors:  Qian Cheng; Fuwen Yuan; Fengmin Lu; Bo Zhang; Tianda Chen; Xiangmei Chen; Yuan Cheng; Na Li; Liwei Ma; Tanjun Tong
Journal:  Oncotarget       Date:  2015-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.